Bodick Neil 4
4 · Flexion Therapeutics Inc · Filed May 11, 2018
Insider Transaction Report
Form 4
Bodick Neil
Chief Medical Officer
Transactions
- Exercise/Conversion
Stock option (right to buy)
2018-05-11−37,702→ 0 totalExercise: $0.16Exp: 2019-09-23→ Common Stock (37,702 underlying) - Exercise/Conversion
Common Stock
2018-05-11$0.16/sh+37,702$6,130→ 112,307 total
Holdings
- 388,683(indirect: By LLC)
Common Stock
- 1,000(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]The shares are held by Versant Development Fund III, LLC. The Reporting Person is a manager and minority member of Versant Development Fund III, LLC. The Reporting Person disclaims any beneficial ownership of the shares held by Versant Development Fund III, LLC except to the extent of his pecuniary interest in these shares.
- [F2]The stock option is fully vested and exercisable.